510(k) Report

510(k) · Cleared

Cleared

Quikstrip One Step Methamphetamine

K970395510(k) TraditionalCleared Jun 26, 1997143-day reviewClass II21 CFR 862.3100

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Drial Consultants, Inc. · DKZ Enzyme Immunoassay, Amphetamine

Cleared on Jun 26, 1997 after a 143-day review. The FDA summary names no predicate by number. 2 later devices descend from it.

Decided
Jun 26, 1997
Review
143 days
Class
Class II
Product code
DKZ
Recalls
None
Predicates
0

2 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2000: 2 descendants cleared1995200020052010201520202025
  1. This deviceK970395 Quikstrip One Step MethamphetamineDrial Consultants, Inc. · 1997
  2. Descendant · cites it directly · 0 of its ownK994406 Instant-View Methamphetamine Urine Dip Strip TestAlfa Scientific Designs, Inc. · 2000
  3. Descendant · cites it directly · 0 of its ownK994400 Instant-View Methamphetamine Urine Cassette TestAlfa Scientific Designs, Inc. · 2000

Most influential descendants

Showing 2 of 2 · See all
  • K994406Instant-View Methamphetamine Urine Dip Strip TestAlfa Scientific Designs, Inc. · 2000 · cites it directly0descendants
  • K994400Instant-View Methamphetamine Urine Cassette TestAlfa Scientific Designs, Inc. · 2000 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K970395Quikstrip One Step MethamphetamineDrial Consultants, Inc.1997—
+1K994406Instant-View Methamphetamine Urine Dip Strip TestAlfa Scientific Designs, Inc.2000—
+1K994400Instant-View Methamphetamine Urine Cassette TestAlfa Scientific Designs, Inc.2000—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200020
FIG. 1 — Lineage of K970395, 1997–2000Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DKZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DKZ device

  1. #1 K233019 AllTest Multi-Drug Rapid Test Cup; AllTest…score 14.6 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

The FDA summary names no predicate by number.

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K994406Instant-View Methamphetamine Urine Dip Strip TestAlfa Scientific Designs, Inc.20000
K994400Instant-View Methamphetamine Urine Cassette TestAlfa Scientific Designs, Inc.20000

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K994406 (Alfa Scientific Designs, Inc., 2000) has gone furthest, with 0 descendants of its own.

How does its category compare?

All DKZ devices

DKZ Enzyme Immunoassay, Amphetamine: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DKZ

1in 2024

2008: 22009: 22010: 42011: 62012: 52013: 82014: 82015: 52016: 52018: 32019: 32020: 12023: 22024: 1
2007high 8 (2013) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DKZ

180in 2019

2010: 233 days median2011: 123 days median2012: 55 days median2013: 103 days median2014: 128 days median2015: 107 days median2016: 215 days median2018: 128 days median2019: 180 days median
2007high 233 (2010) · low 55 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DKZ

1in 2017

2007: 12008: 32009: 52011: 42013: 12014: 32017: 1
2007high 5 (2009) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DKZ

2in 2025

2008: 122009: 12010: 12011: 22013: 12014: 92015: 82016: 82021: 32022: 42023: 72024: 12025: 2
2007high 12 (2008) · low 0 (2007)2025

MAUDE reports naming product code DKZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—10
20082—312
20092—51
2010423301
2011612342
201255500
2013810311
2014812839
2015510708
2016521508
20170—10
2018312800
2019318000
20201—00
20210—03
20220—04
20232—07
20241—01
20250—02
20260—0—

What is it indicated for?

INTENDED USE

Syntron’s QuikStrip One Step Methamphetamine assay 1s a rapid, qualitative, competitive binding immunoassay for the determination of

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K970395: Quikstrip One Step Methamphetamine.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K970395

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026